Seeking Alpha

Alnylam Pharma (ALNY +3.2%) gets a positive opinion for Orphan Drug Designation from European...

Alnylam Pharma (ALNY +3.2%) gets a positive opinion for Orphan Drug Designation from European Medicines Agency for its ALN-TTR01, an RNAi therapeutic. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)